Published 2006
| Version v1.0.0
Journal Article
Open
Trial of Dexmethylphenidate (Focalin) ER in ADHD
Creators
Abstract
The efficacy and safety of dexmethylphenidate extended release (d-MPH-ER) was compared to placebo in 97 patients (ages 6-17 years) with attention-deficit/hyperactivity disorder (ADHD) in a multicenter, randomized, double-blind, two-phase study reported from New York State Psychiatric Institute, New York.Files
PNB-20-54.pdf
Files
(2.4 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:526b740d0ac44d69bc5aeccfcaf1136e
|
2.4 MB | Preview Download |
Additional details
Identifiers
- Other
- PNB-20-54
Dates
- Created
-
2006When the item was originally created.